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ABSTRACT – PURPOSE: Blumea lacera (B. lacera) (Asteraceae) is a well-known Bangladeshi medicinal 
plant. This study aimed to identify and characterize constituents associated with the significant cytotoxic activity 
of this plant that we reported previously. Here, we describe the isolation and characterization of a new steroidal 
glycoalkaloid (SGA) 1, the evaluation of its cytotoxic activity, apoptotic potential, and effect on cell cycle in 
comparison to analogous steroidal glycoalkaloids (SGAs). METHODS: SGA 1 was isolated using C18 SPE and 
HPLC, and subsequently structurally characterized using 1D and 2D NMR, MS and other spectroscopic 
methods, along with a comparative inspection of the literature. Cytotoxic activity of 1 and seven SGA analogues 
and steroidal alkaloids (SAs), (β-solamarine, α-solanine, β-solamargine, α-solasonine, khasianine, solasodine, 
tomatidine HCl) were evaluated for their cytotoxicity against two healthy (NIH3T3 and VERO) and four human 
cancer (AGS, HT-29, MCF-7 and MDA-MB-231) cell lines using the MTT assay. Cytotoxic SGAs were further 
evaluated for apoptosis-inducing potential and cell cycle arresting ability against breast cancer cells (MCF-7) 
using the FITC Annexin V and propidium iodide (PI) assay. RESULTS: Bioactivity guided fractionation of the 
methanol extract of B. lacera led to isolation of compound 1: (25R)-3β-{O-β-D-glucopyranosyl-(1→4)-O-α-L-
rhamnopyranosyl-(1→4)-[O-α-L-rhamnopyranosyl-(1→2)]-α-L-rhamnopyranosyl}-22αN-spirosol-5-ene. SGA 
1 was the most cytotoxic compound against a number of human cancer cell lines with an IC50 of 2.62 µM 
against MCF-7 cells. It displayed the highest apoptotic potential (32% AV+/PI-) on MCF-7 cells compared to 
other cytotoxic SGA analogues and a slight, but significant cell cycle arresting effect. CONCLUSIONS: A new 
SGA 1 was isolated from B. lacera and its cytotoxic activity, as well as that of other SAGs, was evaluated. SAR 
investigations on SGA 1, in relation to SGA analogues, show that the number and nature of sugar moieties along 
with the linkages of the sugar to the aglycone are crucial for cytotoxic and apoptotic activity. 
  
This article is open to POST-PUBLICATION REVIEW. Registered readers (see “For 
Readers”) may comment by clicking on ABSTRACT on the issue’s contents page. 
__________________________________________________________________________________________ 
 
INTRODUCTION 
 
Blumea lacera (Burn. f.) DC. (Asteraceae) is a 
herbaceous weed locally known as Kukursunga in 
Bangladesh (1). It is also commonly found in India, 
Australia, China, Malaya and tropical Africa (2). 
The plant is used traditionally as an anthelmintic, 
astringent, diuretic, anti-scorbutic, anti-dysentric, 
antimicrobial, anti-inflammatory and carminative 
agent, as well as for the treatment of cholera and 
catarrhal infections (3, 4). It is reported to cure 
bronchitis, blood diseases and fevers, and to 
alleviate burning sensations (2). The hot water 
extract of B. lacera has been reported to have anti-
leukemic activity against anti-K562, L1210, 
P3HR1, Raji and U937 leukemia cells (5). 
Recently, we reported on the cytotoxic activity of 
methanolic and water extracts of B. lacera against a 
number of human cancer cell lines (6). 
Phytochemical studies of the plant have thus far 
reported the isolation of a total of 17 compounds 
belonging to natural product classes such as 
flavonoids, terpene glycosides, phenol glycosides,  
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essential oils, coniferyl alcohol derivatives and 
terpenoid ketones (2, 3, 7-12). Antibacterial and 
antifungal activities of the monoterpene glycosides 
isolated from this plant have also been previously 
reported (4). However, there are no reports to date 
that have attributed the cytotoxic activity, observed 
in extracts of B. lacera, to specific compounds. 
Moreover, so far only the phytosterol campesterol 
has been identified from this plant (13). 
This study reports on a new SGA 1, namely 
(25R)-3β-{O-β-D-glucopyranosyl-(1→4)-O-α-L-
rhamnopyranosyl-(1→4)-[O-α-L-rhamnopyranosyl-
(1→2)]-α-L-rhamnopyranosyl}-22αN-spirosol-5-
ene isolated and characterized from the methanolic 
extract of B. lacera leaves. SGAs are comprised of 
an aglycone and a sugar moiety, with both the 
aglycone and sugar moieties impacting on the 
compound’s bioactivity, including their cytotoxic 
and anticancer activity (14-17). For some SGAs, 
but not all, the structure-activity relationship (SAR) 
regarding their cytotoxic activity has been reported 
(14-17).  
In this study, the new SGA 1, as well as seven 
structurally similar SGAs and SAs (β-solamarine, 
α-solanine, β-solamargine, α-solasonine, 
khasianine, solasodine, tomatidine HCl) were 
evaluated for cytotoxicity against two healthy 
(NIH3T3 and VERO) and four human cancer 
(AGS, HT-29, MCF-7 and MDA-MB-231) cell 
lines using the MTT assay. In addition, apoptosis 
and cell cycle studies were performed for 
compound 1 and the cytotoxic SGAs (many of 
which had previously not been evaluated in this 
way) to identify the mechanism of cytotoxic 
activity, determine SARs and evaluate these 
compounds for their potential in anticancer therapy. 
 
METHODS 
 
General experimental procedures 
Optical rotation was measured on a JASCO P-1010 
polarimeter. The UV and IR spectra were recorded 
on a Shimadzu BioSpec-mini and a Bruker Optics 
alpha-QuickSnap (A220/D-01) spectrophotometer, 
respectively. NMR spectra (1H NMR, 13C NMR, 
1H-1H COSY, HSQC and HMBC) were recorded on 
either a Bruker Avance 300 or 600 MHz 
spectrometer in CD3OD with TMS as an internal 
standard. The chemical shifts (δ) are expressed in 
ppm and the coupling constants (J) are in Hz. The 
mass spectra (LRMS and HRESIMS) were recorded 
on a Bruker Daltonics Esquire 3000 and Bruker 
Daltonics Apex III 4.7e spectrometers, respectively. 
Analytical HPLC was performed on a Varian 
Prostar instrument with a 335 DAD using a RP 
(Luna C18, 5 μm, 250 × 4.6 mm) column. 
Preparative HPLC was performed on a Waters 
instrument equipped with a Waters 600E pump, 
Rheodyne 7725i injector, and Waters 2487 dual-
wavelength detector using a RP (Luna C18, 5 μm, 
150 x 21.2 mm) column. SPE cartridges (Alltech, 
10 g, RP-C18) were used to fractionate the extract. 
 
Plant material  
The leaves of B. lacera were collected from the 
Southern part of Bangladesh in May 2007. A 
voucher specimen of B. lacera (No. DACB 30550) 
was identified by Dr. Momtaz Mahal Mirza, 
Principal Scientific Officer, Bangladesh National 
Herbarium, Dhaka and was deposited in the 
Bangladesh National Herbarium, Dhaka.  
 
Extraction and isolation  
The dried and pulverised plant material of B. lacera 
(51.0 g) was extracted by soaking in 500 mL of 
distilled methanol overnight at room temperature 
with continuous stirring. The extract was then 
filtered and the solvent evaporated using a rotary 
evaporator followed by freeze-drying to afford 7.86 
g (15.4 % w/w) of crude methanol extract. The 
extract was further fractionated using a C18 SPE 
column and eluted with a methanol/water stepwise 
gradient (0-100% MeOH in H2O) to provide six 
SPE fractions. Cytotoxicity assays (MTT) on each 
of the SPE fractions was performed and the active 
fraction SPE5 was further subjected to purification 
using semi-preparative RP-HPLC (Luna 5 µm, 150 
x 21.2 mm) using a H2O/ACN gradient system 
containing 0.05% TFA. Semi-preparative HPLC of 
SPE5 (0.5 g) afforded the new SGA 1 (114.1 mg).  
 
Cell culture and chemicals 
All cell lines (VERO, ATCC: CCL-81; NIH 3T3, 
ATCC: CRL-1658; AGS, ATCC: CRL-1739; HT-
29, ATCC: HTB-38; MCF-7, ATCC: HTB-22; and 
MDA-MB-231, ATCC: HTB-26) were purchased 
from ATCC, Manassas, VA 20108, USA. Cell lines 
were cultured in Advanced Dulbecco’s modified 
Eagle’s medium supplemented with 10% 
inactivated newborn calf serum and 5 mM l-
glutamine, and grown at 37°C in a humidified 
atmosphere of 5% CO2 in air. DMSO, MTT, 
cycloheximide and paclitaxel were purchased from 
Sigma Aldrich, Germany. Annexin V-FITC and 
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propidium iodide were purchased from BD 
Biosciences, NJ, USA. 
 
Cytotoxicity assay (MTT) 
In vitro cytotoxicity of the isolated SGA 1 was 
tested against normal mouse fibroblast (NIH3T3) 
and monkey kidney (VERO) cells, as well as four 
human cancer cell lines (gastric adenocarcinoma 
(AGS), colon adenocarcinoma (HT-29), and two 
breast ductal carcinoma cell lines (MCF-7: estrogen 
dependent and MDA-MB-231: estrogen non-
dependent), using the MTT assay. Briefly, cells 
were seeded in 96-well plates at a density of 1.0 × 
104 to 2.0 × 104 cells/well. Following 24 h 
incubation at 37°C with 5% CO2, cells were treated 
with varying concentrations of SGAs and SAs for 
48 h. Following washing and incubation with MTT 
solution for 2 h, cells were lysed. The absorbance 
was measured after 45 min using a microplate 
reader (Wallac 1420 Multilevel counter, Perkin-
Elmer) at a wavelength of 560 nm. The IC50 values 
were calculated with probit analysis software (LdP 
Line Software, Doki, Cairo). Cycloheximide was 
used as a positive control, generating IC50 values of 
8.53, 11.02, 22.39, 24.45, 26.44 and 181.87 μM 
against AGS, HT29, MDA-MB-231, VERO, 
NIH3T3 and MCF-7 cells, respectively. 
 
Apoptosis assay 
The annexin V-FITC apoptosis assay was used to 
measure apoptosis of the isolated cytotoxic SGA 1 
from B. lacera against a human breast cancer MCF-
7 cell line. Briefly, cells were seeded in a 6-well 
plate at a density of 50 × 104 cells/well and 
incubated at 37°C with 5% CO2 for 24 h. The 
following day, cells were treated with IC50 
concentrations of 1 and other SGAs for 24 and 48 h. 
Cells were rinsed with PBS, trypsinized rapidly, 
and centrifuged to pellet the cells. The supernatant 
was removed, and the cells were resuspended in 1× 
binding buffer (0.1 M Hepes/NaOH, 1.4 M NaCl, 
25 mM CaCl2), and 5 μL aliquots of the staining 
solutions (FITC annexin V and PI) were added. 
After 15 min incubation in the dark at room 
temperature, the cell suspension was diluted with 
binding buffer and analyzed within 1 h using a 
CyAn TM ADP flow cytometer (Beckman Coulter, 
USA) with data recorded using HyperCyt (R) 
software. The assay was carried out as two separate 
experiments and each experiment performed in 
triplicate. Cells with no treatment served as the 
negative control and paclitaxel (0.023 µM) served 
as the positive control.  
 
Cell cycle analysis  
Propidium iodide staining cell cycle analysis was 
used to measure the cell distribution in 3 different 
phases of the cell cycle after treatment with 1 
against breast carcinoma cells (MCF-7)). Briefly, 
for cell cycle analysis using flow cytometry, 15 x 
104 cells/well were seeded in 12-well plates and 
incubated at 37°C with 5% CO2 for 24 h. Following 
attachment of the cells after 24 h, the cells were 
treated with 1 and other SGAs at their IC50 
concentrations for 24 h, after which the cells were 
harvested by trypsinization, washed with PBS and 
fixed with 70% ice cold ethanol. After 15 minutes 
incubation and following centrifugation, the fixed 
cells were incubated with 250 µL RNase A solution 
(0.2 mg/mL RNase and 10% Triton X-100) in PBS 
and incubated for 40 minutes at 37°C. The cell 
suspension was then transferred to a falcon 
polystyrene U bottom tube (5 mL) and re-
suspended with 10 µL (1 mg/mL) of propidium 
iodide. Cell cycle distribution was analysed using a 
CyAnTM ADP flow cytometer (Beckman Coulter, 
USA) and the data recorded using HyperCyt (R) 
software. The results were analyzed using De novo 
FCS express 4 Flow Cytometry software. Cells with 
no treatment served as the negative control and 
paclitaxel (0.023 µM) served as the positive control. 
 
RESULTS  
 
Isolation and structural characterisation of the 
new SGA 1 
SGA 1 was isolated and purified from the methanol 
extract of B. lacera leaves using C18 SPE and 
HPLC. The structure of 1 was elucidated by 1D and 
2D NMR, MS and other spectroscopic methods. 
Isolated 1 was obtained as a white amorphous 
powder. Positive-ion mode HR-ESI-MS generated a 
quasi-molecular ion [M+H]+ at m/z 1014.5616, 
consistent with the molecular formula C51H84NO19. 
The measured optical rotation of the compound was 
[α]25D = -94.4◦ (MeOH). The UV spectrum 
displayed λmax at 238 and 202 nm, while the IR 
spectrum showed major absorption bands at cm-1: 
3380 (OH or NH), 2934 (C-H), 1669 cm-1 (C=C), 
1200-1000 cm-1 (C-O). Table 1 presents the 1H and 
13C NMR spectroscopic data.  
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 Table 1. 1H and 13C NMR chemical shifts for SGA 1 (CD3OD, 300 and 75 MHz, respectively). 
Position δH (ppm) (multiplicity, J, Hz)  δC (ppm) 
Aglycone   
1 1.85, 1.05 (2 x m, 2H) 38.4 
2 1.89 (m, 2H) 30.7 
3 3.55  (m, 1H) 79.5 
4 2.27, 2.46 (2 x m, 2H ) 39.4 
5  141.8 
6 5.39 (br s, 1H, J=4.5) 122.5 
7 2.06, 1.98 (2 x m, 2H) 33.0 
8 1.69 (m,1H) 32.7 
9 0.97 (d, 1H, J=6.3) 51.5 
10  38.0 
11 1.58 (m, 2H) 21.9 
12 1.79, 1.83 (2 x m, 2H) 40.3 
13  42.1 
14 2.11 (m, 1H) 57.6 
15 1.85, 1.89 (2 x m, 2H) 33.2 
16 4.63 (dd, 1H, J=7.5, 7.5) 84.7 
17 1.91 (m, 1H) 62.9 
18 0.86 (s, 3H) 16.5 
19 1.05 (s, 3H) 19.8 
20 2.34 (m, 1H, J=7.5) 42.8 
21 1.15 (d, 3H, J=7.2) 14.7 
22  100.2 
23 1.85, 1.89 (2 x m, 2H) 33.1 
24 1.71- 1.77 (m, 2H) 28.9 
25 1.88 (m, 1H) 29.3 
26 2.88, 3.06 (2 x m, 2H)  46.7 
27 0.97 (d, 3H, J=6.3) 18.6 
Sugar Residues   
Glc    
1 4.50 (d, 1H, J=7.8) 100.4 
2 3.55 (m, 1H) 80.8 
3 4.35 (m, 1H) 76.6 
4 3.56 (m, 1H) 77.9 
5 3.59 (m, 1H) 79.1 
6a, 6b 3.65, 3.80 (2 x m, 2H) 61.9 
Rha1   
1 5.19 (d, 1H, J=2.1) 102.3 
2 3.93 (m, 1H) 72.3 
3 3.79 (m, 1H) 72.8 
4 3.40 (m, 1H) 73.8 
5 4.11 (m, 1H) 69.7 
6 (-CH3) 1.24 (d, 3H, J=6.3) 17.9 
Rha2   
1 5.18 (d, 1H, J=1.8) 103.1 
2 3.59  (m, 1H) 72.3 
3 4.04 (m, 1H) 69.0 
4 3.74 (m, 1H) 72.9 
5 3.93 (m, 1H) 72.1 
6 (-CH3) 1.25 (d, 3H, J=6.3) 18.0 
Rha3   
1 4.83 (d, 1H, J=1.2) 102.6 
2 3.64 (m, 1H) 72.3 
3 3.41 (m, 1H) 72.3 
4 3.66 (m, 1H) 73.9 
5 3.70 (m, 1H) 70.4 
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Table 1. Continued…..   
   
6 (-CH3) 1.28 (d, 3H, J=6.0) 18.6 
Glc = -D-Glucopyranose, Rha = -L-Rhamnopyranose
 
 
Cytotoxicity of the isolated new SGA 1 and 
structurally related SGA analogues 
In this study, the isolated SGA 1 was evaluated for 
its cytotoxic activity against two healthy (NIH3T3 
and VERO) and four human cancer (AGS, HT-29, 
MCF-7 and MDA-MB-231) cell lines using the 
MTT assay. Its cytotoxicity was compared to the 
cytotoxicity determined for seven other known and 
structurally related SGAs and SA derivatives, 
namely β-solamarine, α-solanine, β-solamargine, α-
solasonine, khasianine, solasodine, tomatidine HCl. 
Table 2 presents the cytotoxicity results (IC50 
values) of all SGAs tested. Overall, SGA 1 
possesses relatively high cytotoxicity against all the 
cell lines tested (IC50 range 2.6-24 M), with the 
lowest IC50 value of 2.62 M against MCF-7 cells.  
Among the known SGAs and SAs tested, -
solamarine was the most cytotoxic (IC50 range 4.1-
26 M) with an overall similar activity to that 
observed for SGA 1. The cytotoxic activity of -
solamarine against MCF-7 cells (IC50 4.1 M) was 
similar to that observed for SGA 1 but the 
cytotoxicity against the two healthy cell lines tested 
was higher. In addition, khasianine showed weak 
cytotoxic activity only against MCF-7 cells (19.89 
M). Of note, tomatidine HCl and solasodine 
showed no toxicity against any of the cell lines 
tested.  
 
 
Apoptosis assay of the isolated new SGA 1 and 
selected SGA analogues 
To determine whether SGA 1 induces apoptosis, 
and to compare its apoptosis-inducing potential to 
other SGA analogues identified as being cytotoxic 
(β-solamargine, β-solamarine, α-solasonine and α-
solanine), annexin V-FITC apoptosis tests (24 h) 
against MCF-7 cells at their IC50 concentrations 
were conducted. Of all the SGAs tested the new 
SGA 1 showed the highest apoptotic (AV+/PI-) 
effect (32%) that was significantly above untreated 
cells (7.6%) (Figure 1). Amongst the known SGA 
analogues tested, only α-solanine and β-
solamargine exhibited apoptosis-inducing potential 
with 22% (AV+/PI-) and 21% (AV+/PI-), 
respectively (Figure 1).  
 
Cell cycle analysis of the isolated new SGA 1 and 
selected SGA analogues 
To further explore the mechanism by which SGA 1 
and other SGA analogues elicit their cytotoxicity on 
MCF-7 cells, cell cycle analysis using propidium 
iodide (PI) staining was performed. Figure 2 shows 
that cells treated with α-solanine displayed a 
significant increase in the percentage of MCF-7 
cells arrested in S phase (18%), with a 
corresponding decrease in the percentage of cells in 
the G1 (57.8%) and G2/M phases (17%), compared 
to untreated cells (G1 phase: 62.8%, S phase: 6.3% 
and G2/M phase 23.2%). 
 
 
Table 2. Cytotoxic activity (IC50) of the isolated new SGA 1 and other known SGA analogues. 
Compound Cytotoxic activity (IC50)* (µM) 
VERO P35 NIH3T3 AGS HT-29 MCF-7 MDA-MB-231 
SGA 1 24.03 22.33 11.20 10.83 2.62 13.72 
α-Solasodine >100 >100 >100 >100 >100 >100 
α-Solasonine 16.65 11.18 94.32 >100 5.09 8.36 
β-Solamargine 53.94 47.60 21.19 16.36 5.01 20.68 
Khasianine >100 >100 >100 >100 19.89 >100 
β-Solamarine 8.32 5.08 26.08 15.90 4.10 2.55 
α-Solanine 42.39 44.66 31.56 22.39 4.57 6.94 
Tomatidine HCl >100 >100 >100 >100 >100 >100 
Cycloheximide  24.45 26.44 8.53 11.02 181.87 22.39 
IC50* (Inhibition of cell growth by 50%) calculated by probit analysis (LdP Line software, USA), data was generated by 
two experiments performed in triplicates. 
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On the other hand, SGA 1, β-solamargine, β-
solamarine and α-solasonine showed similar 
arresting potentials, and in the case of SGA 1 
significant arrest of MCF-7 cells in the G1 phase 
with a corresponding decrease in the percentage of 
cells in the G2/M (no change in cells in S phase was 
observed) (Figure 2). Paclitaxel, the positive 
control, showed a significant increase in the 
percentage of cells in the G2/M phase, which 
correlates with a decrease in the percentage of cells 
at the G1 phase relative to no treatment, indicating 
that paclitaxel induced G2/M cell cycle arrest. 
 
DISCUSSION 
 
Recently we reported on the cytotoxic activity of 
the methanolic and water extracts of B. lacera 
leaves against a number of human cancer cell lines 
(6). However, there are no reports to date on the 
isolation of cytotoxic compounds from this plant. In 
this study, a new SGA 1 was isolated as a white 
powder from the methanolic extract of B. lacera 
using SPE and HPLC. The 1H NMR data (Table 1, 
Figure S1) of the SGA 1 evidenced a SGA structure 
following close examination of a reported SGA 
(18). Evidencing 16 oxymethine and one 
oxymethylene proton signals indicating the 
presence of three rhamnopyranose and one 
glucopyranose units in the glycone moiety. The 1H 
NMR spectrum evidenced four anomeric sugar 
residue signals at δH 4.50 (d, 1H, J = 7.8 Hz), 4.83 
(d, 1H, J = 1.2 Hz), 5.18 (d, 1H, J = 1.8 Hz) and 
5.19 (d, 1H, J = 2.1 Hz) indicating one β-configured 
(J = 7.8 Hz) and three α-configured (J = 1.2, 1.8 
and 2.1 Hz) sugars, respectively. One oxymethine 
proton signal at δH 4.59 ppm was attributed to ring-
E of the aglycone. The remaining 1H NMR signals 
were consistent with a SGA structure. 
The 13C NMR data (Table 1, Figure S2) of SGA 
1 revealed the presence of fifty one different carbon 
signals, among which twenty seven carbon signals 
were attributed to the aglycone and the remaining 
twenty four consistent with the presence of four 
hexoses. The sixteen oxymethine carbon signals 
between δC 69.0-80.8 ppm and one oxymethylene 
proton signal at δC 61.9 ppm were attributed to 
three -rhamnopyranose and one -glucopyranose 
units. Consistent with this four anomeric carbon 
signals at 100.4 (Glc C-1), 102.3 (Rha1 C-1), 102.6 
(Rha3 C-1), and 103.1 (Rha2 C-1) ppm were also 
evident, indicating again the presence of four sugar 
moieties; one oxymethine carbon signal at δC 84.7 
(C-16) ppm was attributed to ring-E of the 
aglycone. The configuration at C-22 was 
determined as 22-α-N on the basis of carbon shifts 
at C-23, C-24 and C-26 in comparison to published 
13C NMR data (19, 20). The presence of the 25R 
spiroketal moiety and an axial H-25, and equatorial 
configuration of the methyl at C-27 was established 
from 1H and 13C NMR shifts along with 
comparisons to published data (21). The glycosidic 
linkage was shown to be at C-3 of the aglycone, due 
to the downfield shift of C-3 at 79.5 ppm of the 
glycoside when compared with the free aglycone 
(21).  
The HMBC experiment data for SGA 1 along 
with the literature comparison confirmed the 
connectivity between ring-C-ring-D, ring-A-ring-B 
and ring-D-ring-C as well as ring-D-ring-E. The 
methine proton at δH 3.55 (H-3) showed 
connectivity to the anomeric sugar carbon at δC 
100.4 ppm (Glc C-1) indicating the β-Glc C-1 to be 
C-3 linked to the aglycone of SGA 1. In addition, 
connectivity of the proton at δH 3.55 (Glc H-2) to 
the carbon at δC 102.3 (Rha1 C-1) ppm, indicated 
the α-Rha1 C-1 was linked to β-Glc C-2. Cross-
peaks between δH 3.56 (Glc H-4) and δC 103.2 
(Rha2 C-1) ppm indicated the α-Rha2 C-1 was 
linked to β-Glc C-4, while cross peaks between δH 
3.74 (Rha2 H-4) and δC 102.6 (α-Rha3 C-1) ppm 
indicated the Rha3 C-1 was linked to Rha2 C-4 
(Figure 3). 
Based on all NMR spectral data for SGA 1 as 
well as comparing with previously published SGA 
data the aglycone moiety of SGA 1 was assigned as 
(3β, 22α, 25R)-spirosol-5-ene (18-21) and therefore, 
the structure of the isolated compound 1 was 
assigned as a new SGA, namely (25R)-3β-{O-β-D-
glucopyranosyl-(1→4)-O-α-L-rhamnopyranosyl-
(1→4)-[O-α-L-rhamnopyranosyl-(1→2)]-α-L-
rhamnopyranosyl}-22αN-spirosol-5-ene (Figure 4). 
More than 100 structurally different SGAs 
belonging to solanidane and spirosolane classes 
have been identified to date in over 350 Solanum 
species (22, 23). SGAs are comprised of two main 
subunits; an aglycone unit and the glycosidic 
moieties. These compounds possess a wide range of 
bioactivities such as antifungal, anti-inflammatory, 
cytotoxic, antiviral, antioxidant and antimicrobial 
effects. Studies indicate that both, the aglycone and 
glycosidic moieties play crucial roles in exerting 
biological effects, including cytotoxic effects (24-26). 
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Figure 1. Apoptosis induction (AV+/PI-) of SGA 1 and other SGA analogues in MCF-7 cells after 24 h treatment where 
paclitaxel was used as a positive control. 
 
 
 
  
Figure 2. Cell cycle arresting potential of SGA 1 and other SGA analogues on MCF-7 cells following 24 h treatment, 
where paclitaxel was used as a positive control (0.023 µM). 
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Figure 3. Key HMBC and 1H-1H COSY correlations observed in SGA 1. 
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Figure 4. Structure of the new SGA 1. 
 
 
SGA 1 (Figure 4) identified in this study 
possesses the aglycone solasodine and four sugar 
moieties, namely three rhamnopyranose residues 
and a galactopyranose moiety attached at the 3-OH 
position of the aglycone. It was evaluated for its 
cytotoxic potential and mechanism of action.  The 
activity of 1 was, for SAR discussions, compared to 
that of seven structurally related SAGs, namely 
solasodine, α-solasonine, β-solamargine, 
khasianine, β-solamarine, α-solanine and tomatidine 
HCl (Figure 5) that were also evaluated for their 
cytotoxic activity and mechanism.  
In our study α-solasodine showed no cytotoxic 
activity against any of the cell lines tested. 
Similarly α- solasodine was inactive against MCF-7 
and other cell lines tested in a previous study and 
only showed detectable activity against prostate 
cancer (PC3) cells (13.6 µM) (15). In contrast, 
tomatidine HCl, which was also inactive against all 
cell lines tested in our study, inhibited growth of 
human mammary cancer cells, BCAP, in a previous 
study (27).   
A number of studies have reported that SGAs 
are more cytotoxic than their respective aglycones 
alone (17, 28). Our study confirmed this by 
showing no detectable cytotoxic activity for the 
aglycone solasodine, but the same aglycone with 
three sugars attached, namely -solasonine (Gal, 
Rha and Glc in a branched arrangement) showed 
potent selective cytotoxicity.  
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 Figure 5. Structures of selected SGA analogues.  
 
 
Previous studies have found that the type, 
number, as well as order of the sugar residues 
attached to the aglycone have a significant 
influence on the cytotoxic activity of SGAs (14,17), 
and our data support this. In our study khasianine, 
where the glycone is comprised of two sugar 
moieties (-L-Rha-(1-4)--D-Glc-(1-aglycone), 
only showed detectable activity against MCF-7 
cells (IC50 of 19.89 µM). However, SGA 1 with the 
same aglycone as khasianine , but with four sugars, 
two additional sugars to the khasianine arrangement 
(one added to the C4 of the -L-Rha of khasianine, 
the other, -L-Rha, attached to C2 of the --D-Glc 
of khasianine), showed significant toxicity to all 
cell lines tested (e.g. MCF-7 IC50 of 2.62 µM).  
Our study also indicates that the type of 
aglycone does not impact significantly on the 
cytotoxic activity overall if the sugar moieties are 
being kept the same. For example, a comparison of 
-solanine and -solasonine, where the glycone 
contains the exact same sugars and arrangement, 
but the aglycone is variant in rings E and F (see 
Figure 5) indicates that a variation of the aglycone 
does not lead to significant changes in the 
selectivity of cytotoxicity. The cytotoxic activity of 
-solasonine and -solanine on MCF-7 and MDA-
MB-231 cells was similar (IC50 values: 5.09 vs 4.57 
and 8.36 vs 6.94 M). In our study both compounds 
showed greater cytotoxicity against MCF-7 cells 
than previously reported (IC50 values of 10.97 µM 
and 25.44 µM, respectively) (29). We also tested β-
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solamargine for which no cytotoxic activity data 
exists, and determined an IC50 of 5.01 µM against 
estrogen-dependent breast cancer cells (MCF-7). 
This value is similar to the cytotoxic activity 
reported for α-solamargine against MCF-7 (IC50 
values reported: 2.1 µM (30), 2.5 µM (17) and 8.2 
µM (15, 31). Thus, the structural difference 
between β-solamargine and α-solamargine (being a 
β-solasodine vs α-solasodine aglycone, sugar 
moieties are identical, see Figure 5) does not seem 
to significantly influence the cytotoxicity of the 
compounds.  
Moreover, β-solamargine with one Rha more 
than khasianine and one less that SGA 1 exhibited a 
very similar cytotoxicity profile to that of SGA 1.  
This suggests that cytotoxicity is notably enhanced 
with the addition of the second Rha to the linear 
chain (Rha-Rha-Glc-aglycone) and that the addition 
of the third Rha (SGA 1, joined to the Glc (Rha-
Rha-Glc(Rha)-aglycone) does little to further 
enhance this activity. Therefore this demonstrates 
the importance of the two terminal -L-Rha sugars 
on SGA 1 and the significant increase in 
cytotoxicity as a consequence of these being present 
(see Table 2 and Figure 5).  
Apoptosis plays a central role in the 
development and homeostasis of multicellular 
organisms to eliminate unwanted cells. Induction of 
apoptosis of cancer cells plays crucial roles in the 
anticancer activity of many anticancer agents (24). 
To determine whether the SGA 1 induces apoptosis, 
we conducted a 24 h apoptosis assay on SGA 1 and 
other known cytotoxic SGAs against MCF-7 cells 
at their IC50 concentrations.  
In this study, SGA 1 showed the highest 
apoptotic (AV+/PI-) effect (32%) among all the 
SGAs tested. The impact of the number of sugar 
moieties and type of linkage on cytotoxic and 
apoptosis activity of SGAs against various cancer 
cell lines has previously been reported (14, 32). For 
example, α-solamargine was shown to be 4 times 
more apoptotic than khasianine, most likely due to 
the presence of an additional Rha moiety (27). SGA 
1 seems to be similar in its cytotoxicity and 
apoptotic potential to β-solamarine and β-
solamargine, respectively, compounds with very 
similar sugar moiety arrangements and with only a 
slightly different aglycone to SGA 1 (different 
distal stereo-centre on the aglycone at the linkage of 
rings E and F, which defines it as an α or β-
configuration). 
That α-solanine induces apoptosis has been 
reported using human hepatoma cells (33). For α-
solamargine reports exist on apoptosis-inducing 
potential and enhancement of susceptibility to the 
anticancer drugs trastuzumab and epirubicin on 
MCF-7 and other breast cancer cells (SK-BR-3) 
(34), as well as on colon, gastric, liver, lung and 
other cell types (17, 35). However, to our 
knowledge the apoptotic potential of β-solamargine, 
β-solamarine and α-solasonine has not previously 
been reported.  
We also further evaluated the effect of the new 
SGA 1 on the MCF-7 cell cycle using PI staining. 
Treatment with SGA 1 lead to a slight, but 
significant, accumulation of cells in the G1 phase 
(15.7% increase of cells in comparison to untreated 
cells). A similar effect on the MCF-7 cell cycle was 
observed following treatment with β-solamargine, 
β-solamarine and α-solasonine, although the effect 
observed for SGA 1 was slightly more pronounced.  
A clear SAR analysis is difficult given that 
SGA 1, β-solamargine, β-solamarine and α-
solasonine arrest cells in G1 to a similar extent. 
However, the slightly more pronounced effect of 
SGA 1 could be due to the presence of a larger 
number of sugar residues (Figures 1 and 5).  
Importantly, this study provides the first report of 
the effect of β-solamargine, β-solamarine, and α-
solasonine on the cell cycle. Only α-solamargine 
has been investigated previously, showing an arrest 
of lung cancer cells (H441, H520, H661 and H69) 
in their sub-G1 phase (35). Moreover, in contrast to 
the other SGAs tested, here we saw a significant 
increase in the percentage of MCF-7 cells arrested 
in the S-phase for α-solanine, which correlates with 
reports in the literature (29). Our study also found 
that paclitaxel induced G2/M cell cycle arrest, a 
result that is supported by another cell cycle study 
previously performed on MCF-7 with paclitaxel for 
48 h (36). 
In conclusion, the results of this study confirm 
that some SGAs have significant cytotoxic activity, 
with the new SGA 1 and β-solamarine being the 
most cytotoxic SGAs overall. The study also 
highlights the importance of sugar moieties for the 
cytotoxic activity of SGAs and shows for the first 
time apoptotic and cell cycle effects for β-
solamargine, β-solamarine and α-solasonine. 
The potent cytotoxic activity of the new SGA 1 
against MCF-7 cells can be attributed to its ability 
to induce apoptosis, an effect that seems to be due 
to its ability to arrest cells in the G1 phase. The 
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arrest of cells is G1 phase suggests a decrease in the 
expression of proteins (e.g., cyclin D1 and CDK-4) 
that regulate the G1/S checkpoint. Cells that do not 
clear this checkpoint do not pass through to the S 
phase, instead entering the dormant G0 phase in 
which there is no growth or division.  
Further studies investigating for example 
caspase activity, expression of Bcl-2 and Bcl-xL 
and the regulation of HER2/neu will be required to 
further clarify the exact mechanism by which SGA 
1 inhibits the growth of MCF-7 cells. However, our 
study already highlights the great potential of SGA 
1 as an anticancer agent.  
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Figure S1. 1H NMR (600 MHz, CD3OD) spectrum of SGA 1 (CD3OD at 300 MHz). 
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Figure S2. 13C NMR (Jmod, CD3OD at 75 MHz) spectrum of the new SGA 1.  
 
Graphs of cytotoxicity tests of SGA 1 and the selected SGA analogues 
A total of eight SGAs including the new SGA 1 have been tested for their cytotoxic activity against different 
cancer as well as healthy cell lines at different concentrations. All SGAs showed concentration dependent 
cytotoxicity (Figures S3-S10).  
 
 Figure S3. Percent (%) of cell growth inhibition of SGA 1 against the tested cell lines. 
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 Figure S4. Percent (%) of cell growth inhibition of -solasodine against the tested cell lines. 
 
 Figure S5. Percent (%) of cell growth inhibition of SGA α-solasonine against the tested cell lines. 
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 Figure S6. Percent (%) of cell growth inhibition of SGA β-solamargine against the tested cell lines. 
 
 
 Figure S7. Percent (%) of cell growth inhibition of SGA khasianine against the tested cell lines. 
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 Figure S8. Percent (%) of cell growth inhibition of SGA β-solamarine against the tested cell lines. 
 
 
 Figure S9. Percent (%) of cell growth inhibition of SGA α-solanine against the tested cell lines. 
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 Figure S10. Percent (%) of cell growth inhibition of tomatidine HCl against the tested cell lines. 
 
 
 
 
